Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02224599
Title Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kiromic, Inc.

Advanced Solid Tumor


Autologous TAPA-pulsed dendritic cell vaccine + Cyclophosphamide

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.